Status:
UNKNOWN
Improvement of Hand Dysfunction by Arthritis in Systemic Sclerosis
Lead Sponsor:
Prof. Laszlo Czirjak
Collaborating Sponsors:
European Union
University of Giessen
Conditions:
Systemic Sclerosis
Arthritis
Eligibility:
All Genders
Brief Summary
Systemic sclerosis (SSc) is an orphan, multiorgan disease affecting the connective tissue of the skin and several internal organs. Beside skin involvement, digital ulcers, tendinitis, calcinosis and f...
Eligibility Criteria
Inclusion
- Juvenile and adult Systemic sclerosis patients, with diagnosis according to the ACR/EULAR adult SSc criteria and PRES/ACR/EULAR juvenile SSc criteria respectively
- Clinical signs of arthritis (defined as ≥2 tender and swollen joints)
Exclusion
- Presence of significant, long standing articular pain due to other cause than autoimmune disease
- Presence of hand disability caused by other, than autoimmune disease
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2017
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT01834157
Start Date
April 1 2013
End Date
November 1 2017
Last Update
December 22 2015
Active Locations (33)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ghent, Department of Rheumatology
Ghent, Belgium, 9000
2
Dubrava University Hospital
Zagreb, Croatia
3
Assiut and Sohage University Hospital Rheumatology Department Assiut University Hospital
Asyut, Egypt
4
Department of Internal Medicine Hôpital Claude Huriez
Lille, France, 59035